Market Screener
Filter stocks by sector, industry, market cap, valuation, growth, and technicals — in a dense table layout.
| No. | Ticker | Company | Sector | Industry | Country | Market Cap ($B) ▲ | P/E | Price | Chg. % | Volume |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TSHA | Taysha Gene Therapies Inc | Healthcare | Biotechnology | US | 0.0 | — | 5.70 | +5.90% | — |
| 2 | HURA | TuHURA Biosciences Inc | Healthcare | Biotechnology | US | 0.2 | — | 2.40 | 0.00% | — |
| 3 | REPL | Replimune Group Inc | Healthcare | Biotechnology | US | 0.9 | — | 9.90 | -0.70% | — |
| 4 | FTRE | Fortrea Holdings Inc. | Healthcare | Biotechnology | US | 1.6 | — | 18.00 | +1.00% | — |
| 5 | AUPH | Aurinia Pharmaceuticals Inc | Healthcare | Biotechnology | US | 2.2 | — | 16.00 | -0.30% | — |
| 6 | RCUS | Arcus Biosciences Inc | Healthcare | Biotechnology | US | 3.8 | — | 28.30 | +0.90% | — |
| 7 | TGTX | TG Therapeutics Inc | Healthcare | Biotechnology | US | 8.3 | — | 54.90 | -0.20% | — |
| 8 | CYTK | Cytokinetics Inc | Healthcare | Biotechnology | US | 10.9 | — | 81.90 | -0.40% | — |
| 9 | EXEL | Exelixis Inc | Healthcare | Biotechnology | US | 13.4 | — | 55.80 | -0.50% | — |
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).